Discuss defining 'cure' from the patient's viewpoint, covering the treatment journey, efficacy/toxicity trade offs, life milestones, and key questions patients have about their treatment and care

Explore opportunities to optimise care on the path to a functional cure — advancing access and referral pathways, and tailoring treatment strategies to patient preferences and fitness

Exploration of innovations in CAR T-cell therapy as leading contenders in the pursuit of a cure, highlighting the different approaches (e.g. in vivo CARs/dual CARs), key efficacy/safety data, durability of response and the evolving significance of MRD

Two ~7-minute presentations will debate the optimal treatment strategy for a patient case, covering the use of CAR T earlier vs later; the impact of prior lines of therapy; the evidence for earlier intervention in NDMM–RRMM; and navigating real-world considerations to maximise potential for durable, long-term remission